Tag: biomedical
-
Novo Nordisk to Open Oxford Diabetes Research Center
The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K.
-
Immunotherapy Biotech Raises $102 Million in IPO
A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering.
-
Simpler Lab Cell Production Techniques Devised
A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research.
-
Self-Adjusting Lenses Designed for Eyeglasses
An engineering lab at University of Utah developed a system with eyeglass lenses that automatically adjust to the focus of the wearer, to replace bifocals and reading glasses.
-
Trial Planned to Evaluate CTE Blood Test
A clinical trial is planned of a blood test to detect an indicator of chronic traumatic encephalopathy. or CTE. a neurodegenerative disease associated with collision sports.
-
Allergy Immunotherapy Firm Raises $2M in Early Funds
A biotechnology company in Finland developing an allergy vaccine that harnesses the immune system is raising €1.85 million ($US 2 million) in its first venture funding round.
-
News Blackout Imposed on U.S. Science Agencies [Updated]
Multiple news services today are reporting that the Trump administration is ordering several U.S. government agencies conducting or funding scientific research to cease discussing its activities with the media or public officials.
-
Neuro Device Company to Begin Clinical Trials in Europe
Clinical trials in Europe are set to begin to test a non-invasive device that stimulates nerves and the spinal cord to treat neuromotor disorders.
-
Biopharm, Hospital to Partner on Cell Energy Diseases
A biopharmaceutical company in Sweden and children’s hospital in the U.S. are collaborating on research into deficiencies in cells’ energy components responsible for a number of genetic disorders.
-
Safer Engineered-Cell Cancer Immunotherapy Designed
A biotechnology company designed a new type of engineered T-cell from the immune system that more precisely targets tumors and stays away from healthy cells.